Literature DB >> 8097815

Reappraisal of the role of endotoxin in the sepsis syndrome.

J C Hurley1.   

Abstract

There is strong evidence to implicate endotoxin released from gram negative bacteria in the pathogenesis of the sepsis syndrome and related conditions, but equally compelling data bring the role of endotoxin into doubt. Reappraisal of endotoxin and its release from gram negative bacteria suggests that it is not directly responsible for the complications of sepsis syndrome. Rather, release of endotoxin is a marker for the transition of gram negative organisms to cell-wall-deficient forms (L-forms) that may persist undetected despite antibiotic therapy directed against the parental form. This transition has two consequences in compromised patients: L-forms cause organ failure, and they serve as a sanctuary from which cell-wall-intact revertants may arise.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097815     DOI: 10.1016/0140-6736(93)93139-r

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-alpha and endotoxin.

Authors:  M A Mercer-Jones; M Heinzelmann; J C Peyton; D J Wickel; M Cook; W G Cheadle
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

Review 2.  Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.

Authors:  J C Hurley
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

Review 3.  Advanced and controlled drug delivery systems in clinical disease management.

Authors:  J R Brouwers
Journal:  Pharm World Sci       Date:  1996-10

Review 4.  Antibiotic-induced release of endotoxin. A therapeutic paradox.

Authors:  J C Hurley
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

5.  Gram-negative sepsis: what dilemma?

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Rifampicin in pneumococcal meningoencephalitis.

Authors:  M J Peters; B L Pizer; M Millar
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

Review 8.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 9.  Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders.

Authors:  James C Hurley; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

Review 10.  Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Authors:  James C Hurley
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.